Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

Chiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, Sebastian Pünzeler, David Valle-Garcia, Tobias Straub, Eva C. Keilhauer, Thomas Strub, Joanna Dong, Taniya Panda, Chi Yeh Chung, Jonathan L. Yao, Rajendra Singh, Miguel F. Segura, Barbara Fontanals-Cirera, Amit K. Verma, Matthias Mann, Eva Hernando, Sandra B. Hake, Emily Bernstein

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. Wefurther demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targetedtherapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)75-88
Number of pages14
JournalMolecular Cell
Volume59
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Histones
Melanoma
Pharmaceutical Preparations
Cell Proliferation
Genes
Protein Isoforms
Drug Therapy
Survival
Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Vardabasso, C., Gaspar-Maia, A., Hasson, D., Pünzeler, S., Valle-Garcia, D., Straub, T., ... Bernstein, E. (2015). Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. Molecular Cell, 59(1), 75-88. https://doi.org/10.1016/j.molcel.2015.05.009

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. / Vardabasso, Chiara; Gaspar-Maia, Alexandre; Hasson, Dan; Pünzeler, Sebastian; Valle-Garcia, David; Straub, Tobias; Keilhauer, Eva C.; Strub, Thomas; Dong, Joanna; Panda, Taniya; Chung, Chi Yeh; Yao, Jonathan L.; Singh, Rajendra; Segura, Miguel F.; Fontanals-Cirera, Barbara; Verma, Amit K.; Mann, Matthias; Hernando, Eva; Hake, Sandra B.; Bernstein, Emily.

In: Molecular Cell, Vol. 59, No. 1, 2015, p. 75-88.

Research output: Contribution to journalArticle

Vardabasso, C, Gaspar-Maia, A, Hasson, D, Pünzeler, S, Valle-Garcia, D, Straub, T, Keilhauer, EC, Strub, T, Dong, J, Panda, T, Chung, CY, Yao, JL, Singh, R, Segura, MF, Fontanals-Cirera, B, Verma, AK, Mann, M, Hernando, E, Hake, SB & Bernstein, E 2015, 'Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma', Molecular Cell, vol. 59, no. 1, pp. 75-88. https://doi.org/10.1016/j.molcel.2015.05.009
Vardabasso C, Gaspar-Maia A, Hasson D, Pünzeler S, Valle-Garcia D, Straub T et al. Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. Molecular Cell. 2015;59(1):75-88. https://doi.org/10.1016/j.molcel.2015.05.009
Vardabasso, Chiara ; Gaspar-Maia, Alexandre ; Hasson, Dan ; Pünzeler, Sebastian ; Valle-Garcia, David ; Straub, Tobias ; Keilhauer, Eva C. ; Strub, Thomas ; Dong, Joanna ; Panda, Taniya ; Chung, Chi Yeh ; Yao, Jonathan L. ; Singh, Rajendra ; Segura, Miguel F. ; Fontanals-Cirera, Barbara ; Verma, Amit K. ; Mann, Matthias ; Hernando, Eva ; Hake, Sandra B. ; Bernstein, Emily. / Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. In: Molecular Cell. 2015 ; Vol. 59, No. 1. pp. 75-88.
@article{da5b5cd31c8445d09cf6ab4129c98f57,
title = "Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma",
abstract = "Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. Wefurther demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targetedtherapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.",
author = "Chiara Vardabasso and Alexandre Gaspar-Maia and Dan Hasson and Sebastian P{\"u}nzeler and David Valle-Garcia and Tobias Straub and Keilhauer, {Eva C.} and Thomas Strub and Joanna Dong and Taniya Panda and Chung, {Chi Yeh} and Yao, {Jonathan L.} and Rajendra Singh and Segura, {Miguel F.} and Barbara Fontanals-Cirera and Verma, {Amit K.} and Matthias Mann and Eva Hernando and Hake, {Sandra B.} and Emily Bernstein",
year = "2015",
doi = "10.1016/j.molcel.2015.05.009",
language = "English (US)",
volume = "59",
pages = "75--88",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma

AU - Vardabasso, Chiara

AU - Gaspar-Maia, Alexandre

AU - Hasson, Dan

AU - Pünzeler, Sebastian

AU - Valle-Garcia, David

AU - Straub, Tobias

AU - Keilhauer, Eva C.

AU - Strub, Thomas

AU - Dong, Joanna

AU - Panda, Taniya

AU - Chung, Chi Yeh

AU - Yao, Jonathan L.

AU - Singh, Rajendra

AU - Segura, Miguel F.

AU - Fontanals-Cirera, Barbara

AU - Verma, Amit K.

AU - Mann, Matthias

AU - Hernando, Eva

AU - Hake, Sandra B.

AU - Bernstein, Emily

PY - 2015

Y1 - 2015

N2 - Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. Wefurther demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targetedtherapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.

AB - Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. Wefurther demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targetedtherapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=84937164820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937164820&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2015.05.009

DO - 10.1016/j.molcel.2015.05.009

M3 - Article

C2 - 26051178

AN - SCOPUS:84937164820

VL - 59

SP - 75

EP - 88

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 1

ER -